Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4201
iShares ESG Aware MSCI EM ETF
ESGE
$6.81B
| $220K | ﹤0.01% |
+4,981
| New | +$220K |
|
4202
OneWater Marine
ONEW
$204M
| $218K | ﹤0.01% |
20,192
-611
| -3% | -$8.15K |
|
|
CBNA
4203
Chain Bridge Bancorp
CBNA
$318M
| $218K | ﹤0.01% |
6,303
+525
| +9% | +$17K |
|
4204
Flexsteel Industries
FLXS
$301M
| $218K | ﹤0.01% |
5,527
+333
| +6% | +$13K |
|
|
ANDG
4205
Andersen Group
ANDG
$5.65B
| $218K | ﹤0.01% |
+8,400
| New | +$211K |
|
4206
RE/MAX Holdings
RMAX
$263M
| $216K | ﹤0.01% |
28,503
+2,740
| +11% | +$22.2K |
|
4207
Crexendo
CXDO
$215M
| $216K | ﹤0.01% |
33,426
+5,895
| +21% | +$38.6K |
|
4208
Funko
FNKO
$331M
| $216K | ﹤0.01% |
63,555
+14,018
| +28% | +$44.1K |
|
4209
Lightwave Logic
LWLG
$1.23B
| $216K | ﹤0.01% |
66,693
+66,679
| +476,279% | +$296K |
|
4210
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.3B
| $216K | ﹤0.01% |
+9,789
| New | +$216K |
|
4211
Biote Corp
BTMD
$43.1M
| $216K | ﹤0.01% |
82,942
+4,448
| +6% | +$12.2K |
|
4212
Escalade
ESCA
$284M
| $215K | ﹤0.01% |
15,960
+1,711
| +12% | +$21.3K |
|
4213
Treace Medical Concepts
TMCI
$309M
| $215K | ﹤0.01% |
87,664
+6,077
| +7% | +$26.4K |
|
4214
Westwood Holdings Group
WHG
$183M
| $213K | ﹤0.01% |
12,396
+1,190
| +11% | +$20K |
|
4215
Richardson Electronics
RELL
$302M
| $213K | ﹤0.01% |
19,606
-5,131
| -21% | -$54.7K |
|
4216
Ocugen
OCGN
$475M
| $213K | ﹤0.01% |
+157,500
| New | +$224K |
|
4217
Acme United Corp
ACU
$228M
| $213K | ﹤0.01% |
5,274
+575
| +12% | +$22.1K |
|
4218
Motley Fool 100 Index ETF
TMFC
$2.11B
| $212K | ﹤0.01% |
2,960
-427
| -13% | -$30.5K |
|
4219
Ero Copper
ERO
$3.76B
| $212K | ﹤0.01% |
7,508
+6,949
| +1,243% | +$162K |
|
4220
FreightCar America
RAIL
$243M
| $212K | ﹤0.01% |
19,185
+16,192
| +541% | +$149K |
|
|
KLC
4221
KinderCare Learning Companies
KLC
$550M
| $212K | ﹤0.01% |
49,087
+1,520
| +3% | +$7.66K |
|
4222
PUT
Sable Offshore Corp
SOC
$840M
| $211K | ﹤0.01% |
23,400
-6,400
| -21% | -$60.4K |
|
4223
iShares Gold Trust
IAU
$65.4B
| $211K | ﹤0.01% |
2,598
-19,120
| -88% | -$1.5M |
|
4224
Adicet Bio
ACET
$77.3M
| $211K | ﹤0.01% |
25,000
+6,250
| +33% | +$69.1K |
|
|
SUNS
4225
Sunrise Realty Trust
SUNS
$102M
| $209K | ﹤0.01% |
22,183
+1,518
| +7% | +$14.9K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.